2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide;(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione | 65047-12-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide;(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
• CAS: 65047-12-3
• 化学式: C48H79Cl2N3O18
• 分子量: 1057.1
• InChiKey: UZXWPXIRPVJKMF-HBEPNGEBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.69
• 重原子数：
  71
• 可旋转键数：
  12
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.81
• 拓扑面积：
  309
• 氢给体数：
  8
• 氢受体数：
  19

文献信息

• Method and system for modulation and modification of microbial cell characteristics and production of modified microbial materials
  申请人：——

  公开号：US20040023360A1

  公开（公告）日：2004-02-05

  A method and a system is disclosed for the modulation of various characteristics of probiotic cells and for the production of probiotics having altered characteristics. Such altered characteristics include increased resistance to various stresses, drugs and chemical agents, as well as aggregation. Such a method and a system are useful for the production of probiotics with altered characteristics, which may for example provide health benefits when present in the gastrointestinal tract of an animal.

  本发明公开了一种方法和系统，用于调节益生菌细胞的各种特性和生产具有改变特性的益生菌。这些改变的特性包括对各种压力、药物和化学制剂的抗性增强，以及聚集性增强。这种方法和系统可用于生产具有改变特性的益生菌，例如，当益生菌存在于动物的胃肠道中时，可为健康带来益处。
• Methods and constructs for high yield expression of clostripain
  申请人：Wagner W. Fred

  公开号：US20050244924A1

  公开（公告）日：2005-11-03

  The invention provides methods and nucleic acid constructs to express clostripain.

  本发明提供了表达 Clostripain 的方法和核酸构建体。
• ANTIBIOTICS AND PROCESS FOR PREPARATION
  申请人：Truett, William L.

  公开号：EP0970065A1

  公开（公告）日：2000-01-12
• EP0970065A4
  申请人：——

  公开号：EP0970065A4

  公开（公告）日：2001-03-07
• EXOCYTOSIS PATHWAY PROTEINS AND METHODS OF USE
  申请人：Rigel Pharmaceuticals, Inc.

  公开号：EP1161442A2

  公开（公告）日：2001-12-12